Cancer Immunotherapy. Immune Suppression and Tumor Growth

Content: 
Front Matter, Page iii
Copyright, Page iv
List of Contributors, Pages xv-xxii, Paola Allavena, Maria Libera Ascierto, Davide Bedognetti, Daniel W. Beury, Vincenzo Bronte, Sjoerd H. van der Burg, Zheng Cai, Margaret K. Callahan, Bruce D. Car, Gang Chen, Mariacristina Chioda, Olesya Chornoguz, Sandra Demaria, Jiehui Deng, Julie Y. Djeu, Sarah S. Donatelli, Charles G. Drake, Glenn Dranoff, Nicholas M. Durham, Laurence C. Eisenlohr,  et al.
Chapter 1 - Introduction, Pages 1-8, George C. Prendergast, Elizabeth M. Jaffee
Chapter 2 - Components of the Immune System, Pages 11-24, Amanda Norvell
Chapter 3 - Adaptive Immunity: B Cells and Antibodies, Pages 25-40, Lauren M.F. Merlo, Laura Mandik-Nayak
Chapter 4 - Adaptive Immunity: T Cells and Cytokines, Pages 41-53, Jenni Punt
Chapter 5 - Dendritic Cells: Antigen Processing and Presentation, Pages 55-70, Nancy Luckashenak, Laurence C. Eisenlohr
Chapter 6 - Mucosal Immunity, Pages 71-81, Cathryn Nagler, Taylor Feehley
Chapter 7 - Cancer Immunoediting: From Surveillance to Escape, Pages 85-99, Michele W.L. Teng, Michael H. Kershaw, Mark J. Smyth
Chapter 8 - Immunosurveillance: Innate and Adaptive Antitumor Immunity, Pages 101-113, Kenneth F. May Jr., Masahisa Jinushi, Glenn Dranoff
Chapter 9 - Immunological Sculpting: Natural Killer-Cell Receptors and Ligands, Pages 115-127, Sarah S. Donatelli, Julie Y. Djeu
Chapter 10 - Th17 Cells in Cancer, Pages 129-147, Ende Zhao, Lin Wang, Shuang Wei, Ilona Kryczek, Weiping Zou
Chapter 11 - Immune Escape: Immunosuppressive Networks, Pages 149-164, Sandra Demaria
Chapter 12 - Principles of Cytotoxic Chemotherapy, Pages 167-185, Bradley W. Lash, Paul B. Gilman
Chapter 13 - Pharmacokinetics and Safety Assessment, Pages 187-206, Richard A. Westhouse, Bruce D. Car
Chapter 14 - Monoclonal Antibodies for Cancer Therapy and Prevention: Paradigm Studies in Targeting the neu/ERBB2/HER2 Oncoprotein, Pages 207-222, Hongtao Zhang, Arabinda Samanta, Yasuhiro Nagai, Hiromichi Tsuchiya, Takuya Ohtani, Zheng Cai, Zhiqiang Zhu, Jing Liu, Mark I. Greene
Chapter 15 - Genetic Vaccines against Cancer: Design, Testing and Clinical Performance, Pages 223-239, Freda K. Stevenson, Gianfranco di Genova, Christian H. Ottensmeier, Natalia Savelyeva
Chapter 16 - Comprehensive Immunomonitoring to Guide the Development of Immunotherapeutic Products for Cancer, Pages 241-258, Marij J.P. Welters, Sjoerd H. van der Burg
Chapter 17 - Adoptive T-cell Therapy: Engineering T-cell Receptors, Pages 261-272, Richard A. Morgan
Chapter 18 - Dendritic Cell Vaccines: Sipuleucel-T and Other Approaches, Pages 273-286, Nicholas M. Durham, Charles G. Drake
Chapter 19 - Antibodies to Stimulate Host Immunity: Lessons from Ipilimumab, Pages 287-307, Margaret K. Callahan, Michael A. Postow, Jedd D. Wolchok
Chapter 20 - Recombinant TRICOM-based Therapeutic Cancer Vaccines: Lessons Learned, Pages 309-331, Jeffrey Schlom, James W. Hodge, Claudia Palena, John W. Greiner, Kwong-Yok Tsang, Benedetto Farsaci, Ravi A. Madan, James L. Gulley
Chapter 21 - Adjuvant Strategies for Vaccines: The Use of Adjuvants within the Cancer Vaccine Setting, Pages 333-349, Claire Hearnden, Ed C. Lavelle
Chapter 22 - Epigenetic Approaches: Emerging Role of Histone Deacetylase Inhibitors in Cancer Immunotherapy, Pages 353-372, Eva Sahakian, Karrune Woan, Alejandro Villagra, Eduardo M. Sotomayor
Chapter 23 - Molecular Profiling of Immunotherapeutic Resistance, Pages 373-394, Davide Bedognetti, Ena Wang, Marimo Sato-Matsushita, Francesco M. Marincola, Maria Libera Ascierto
Chapter 24 - Immune Stimulatory Features of Classical Chemotherapy, Pages 395-414, W. Joost Lesterhuis, Anna K. Nowak, Richard A. Lake
Chapter 25 - Immunotherapy and Cancer Therapeutics: A Rich Partnership, Pages 415-432, Gang Chen, Elizabeth M. Jaffee, Leisha A. Emens
Chapter 26 - JAK/STAT Signaling in Myeloid Cells: Targets for Cancer Immunotherapy, Pages 435-449, Saul J. Priceman, Jiehui Deng, Richard Jove, Hua Yu
Chapter 27 - Tumor-associated Macrophages in Cancer Growth and Progression, Pages 451-471, Alberto Mantovani, Maria Rosaria Galdiero, Paola Allavena, Antonio Sica
Chapter 28 - Tumor-induced Myeloid-derived Suppressor Cells, Pages 473-496, Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W. Beury, Olesya Chornoguz, Katherine H. Parker
Chapter 29 - HyperAcute Vaccines: A Novel Cancer Immunotherapy, Pages 497-516, Gabriela R. Rossi, Nicholas N. Vahanian, W. Jay Ramsey, Charles J. Link
Chapter 30 - Tumor Exosomes and Their Impact on Immunity and Cancer Progression, Pages 517-535, Veronica Huber, Paola Filipazzi, Licia Rivoltini
Chapter 31 - Galectins: Key Players in the Tumor Microenvironment, Pages 537-563, Victoria Sundblad, Veronique Mathieu, Robert Kiss, Gabriel A. Rabinovich
Chapter 32 - IDO in Immune Escape: Regulation and Therapeutic Inhibition, Pages 565-581, Alexander J. Muller, Courtney Smith, Richard Metz, George C. Prendergast
Chapter 33 - IDO Pathway: Effect on Foxp3+ Tregs and Cancer, Pages 583-596, David H. Munn, Andrew L. Mellor
Chapter 34 - Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation, Pages 597-634, Mariacristina Chioda, Ilaria Marigo, Susanna Mandruzzato, Simone Mocellin, Vincenzo Bronte
Index, Pages 635-655